Yu Fu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Yu Fu has a total of 60 co-authors. Here are the top co-authors by number of shared publications:
- Hongbing Jiang
Nanjing Medical University
33 shared publications - Laikui Liu
Department of Basic Science of Stomatology The Affiliated Stomatological Hospital of Nanjing Medical University Nanjing China
27 shared publications - Rongyao Xu
The Affiliated Stomatological Hospital of Nanjing Medical University
27 shared publications - Jie Cheng
Department of Oral and Maxillofacial Surgery, The Affiliated Stomatological Hospital, Nanjing Medical University, Jiangsu, China
25 shared publications - Jinhai Ye
Department of Oral and Maxillofacial Surgery, Zhongshan Hospital, Fudan University;
25 shared publications - Yangjie Li
Department of Oral and Maxillofacial Surgery, Affiliated Hospital of Stomatology, Nanjing Medical University, Nanjing, China
25 shared publications
Latest Publications
- 15 March 2026
- Published by Taylor & Francis in Autophagy
- Vol. 22 (9) , 2079-2100
Impaired mitophagy contributes to osteogenesis and mineralization disorders in fibrous dysplasia
Fibrous dysplasia (FD) is a bone mesenchymal stromal cells (BMSCs)-derived disorder caused by GNAS gene mutation, characterized by excessive fibrous tissue proliferation in bone and the formation of immature trabecular bone. Although impaired osteogenesis of BMSCs is central to FD pathogenesis, the underlying mechanism remains largely elusive. Here we demonstrate that hyperactivation of the cAMP-PRKA/PKA signaling axis disrupts mitochondrial homeostasis through impaired mitophagy, ultimately leading to diminished amorphous calcium phosphate (ACP) secretion and consequent mineralization failure in FD. Mechanistically, in FD BMSCs, PRKA activation inhibits DNM1L/DRP1 recruitment to mitochondria through phosphorylation at S637, thereby suppressing mitochondrial fission. Consequently, excessive mitochondrial fusion leads to an elevated mitochondrial membrane potential, impaired mitophagy, and diminished ACP release. Collectively, our findings reveal a novel signaling nexus linking cAMP-PRKA signaling, mitochondrial dynamics, and biomineralization processes in FD pathogenesis, providing critical insights into the molecular basis of this disorder.
- 15 March 2026
- Published by Taylor & Francis in Autophagy
- Vol. 22 (9) , 2079-2100
Impaired mitophagy contributes to osteogenesis and mineralization disorders in fibrous dysplasia
Fibrous dysplasia (FD) is a bone mesenchymal stromal cells (BMSCs)-derived disorder caused by GNAS gene mutation, characterized by excessive fibrous tissue proliferation in bone and the formation of immature trabecular bone. Although impaired osteogenesis of BMSCs is central to FD pathogenesis, the underlying mechanism remains largely elusive. Here we demonstrate that hyperactivation of the cAMP-PRKA/PKA signaling axis disrupts mitochondrial homeostasis through impaired mitophagy, ultimately leading to diminished amorphous calcium phosphate (ACP) secretion and consequent mineralization failure in FD. Mechanistically, in FD BMSCs, PRKA activation inhibits DNM1L/DRP1 recruitment to mitochondria through phosphorylation at S637, thereby suppressing mitochondrial fission. Consequently, excessive mitochondrial fusion leads to an elevated mitochondrial membrane potential, impaired mitophagy, and diminished ACP release. Collectively, our findings reveal a novel signaling nexus linking cAMP-PRKA signaling, mitochondrial dynamics, and biomineralization processes in FD pathogenesis, providing critical insights into the molecular basis of this disorder.
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary file 2: Supplementary Figures and Legends. from circFNDC3B Accelerates Vasculature Formation and Metastasis in Oral Squamous Cell Carcinoma
Supplementary Figures and Legends.
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary file 2: Supplementary Figures and Legends. from circFNDC3B Accelerates Vasculature Formation and Metastasis in Oral Squamous Cell Carcinoma
Supplementary Figures and Legends.
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary file 1: Supplementary Materials and Methods. from circFNDC3B Accelerates Vasculature Formation and Metastasis in Oral Squamous Cell Carcinoma
Supplementary Materials and Methods.
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary file 1: Supplementary Materials and Methods. from circFNDC3B Accelerates Vasculature Formation and Metastasis in Oral Squamous Cell Carcinoma
Supplementary Materials and Methods.
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Data from circFNDC3B Accelerates Vasculature Formation and Metastasis in Oral Squamous Cell Carcinoma
Emerging evidence has demonstrated that circular RNAs (circRNA) are involved in cancer metastasis. Further elucidation of the role of circRNAs in oral squamous cell carcinoma (OSCC) could provide insights into mechanisms driving metastasis and potential therapeutic targets. Here, we identify a circRNA, circFNDC3B, that is significantly upregulated in OSCC and is positively associated with lymph node (LN) metastasis. In vitro and in vivo functional assays showed that circFNDC3B accelerated the migration and invasion of OSCC cells and the tube-forming capacity of human umbilical vein endothelial cells and human lymphatic endothelial cells. Mechanistically, circFNDC3B regulated ubiquitylation of the RNA-binding protein FUS and the deubiquitylation of HIF1A through the E3 ligase MDM2 to promote VEGFA transcription, thereby enhancing angiogenesis. Meanwhile, circFNDC3B sequestered miR-181c-5p to upregulate SERPINE1 and PROX1, which drove epithelial–mesenchymal transition (EMT) or partial-EMT (p-EMT) in OSCC cells and promoted lymphangiogenesis to accelerate LN metastasis. Overall, these findings uncovered the mechanistic role of circFNDC3B in orchestrating cancer cell metastatic properties and vasculature formation, suggesting circFNDC3B could be a potential target to reduce OSCC metastasis.Significance:Dual functions of circFNDC3B in enhancing the metastatic ability of cancer cells and promoting vasculature formation through regulation of multiple pro-oncogenic signaling pathways drive lymph node metastasis of OSCC.
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessData from circFNDC3B Accelerates Vasculature Formation and Metastasis in Oral Squamous Cell Carcinoma
Emerging evidence has demonstrated that circular RNAs (circRNA) are involved in cancer metastasis. Further elucidation of the role of circRNAs in oral squamous cell carcinoma (OSCC) could provide insights into mechanisms driving metastasis and potential therapeutic targets. Here, we identify a circRNA, circFNDC3B, that is significantly upregulated in OSCC and is positively associated with lymph node (LN) metastasis. In vitro and in vivo functional assays showed that circFNDC3B accelerated the migration and invasion of OSCC cells and the tube-forming capacity of human umbilical vein endothelial cells and human lymphatic endothelial cells. Mechanistically, circFNDC3B regulated ubiquitylation of the RNA-binding protein FUS and the deubiquitylation of HIF1A through the E3 ligase MDM2 to promote VEGFA transcription, thereby enhancing angiogenesis. Meanwhile, circFNDC3B sequestered miR-181c-5p to upregulate SERPINE1 and PROX1, which drove epithelial–mesenchymal transition (EMT) or partial-EMT (p-EMT) in OSCC cells and promoted lymphangiogenesis to accelerate LN metastasis. Overall, these findings uncovered the mechanistic role of circFNDC3B in orchestrating cancer cell metastatic properties and vasculature formation, suggesting circFNDC3B could be a potential target to reduce OSCC metastasis.Significance:Dual functions of circFNDC3B in enhancing the metastatic ability of cancer cells and promoting vasculature formation through regulation of multiple pro-oncogenic signaling pathways drive lymph node metastasis of OSCC.
- Open Access
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Supplementary file 1: Supplementary Materials and Methods. from circFNDC3B accelerates vasculature formation and metastasis in oral squamous cell carcinoma
Supplementary Materials and Methods.
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary file 1: Supplementary Materials and Methods. from circFNDC3B accelerates vasculature formation and metastasis in oral squamous cell carcinoma
Supplementary Materials and Methods.
- Open Access
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Supplementary file 3: Supplementary Tables. from circFNDC3B accelerates vasculature formation and metastasis in oral squamous cell carcinoma
Supplementary file 3: Supplementary Tables. from circFNDC3B accelerates vasculature formation and metastasis in oral squamous cell carcinoma
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary file 3: Supplementary Tables. from circFNDC3B accelerates vasculature formation and metastasis in oral squamous cell carcinoma
Supplementary file 3: Supplementary Tables. from circFNDC3B accelerates vasculature formation and metastasis in oral squamous cell carcinoma
- Open Access
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Supplementary file 1: Supplementary Materials and Methods. from circFNDC3B accelerates vasculature formation and metastasis in oral squamous cell carcinoma
Supplementary Materials and Methods.
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary file 1: Supplementary Materials and Methods. from circFNDC3B accelerates vasculature formation and metastasis in oral squamous cell carcinoma
Supplementary Materials and Methods.